Literature DB >> 20682902

Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007.

Mohamed Mohamed1, Fausta Mosha, Janeth Mghamba, Sherif R Zaki, Wun-Ju Shieh, Janusz Paweska, Sylvia Omulo, Solomon Gikundi, Peter Mmbuji, Peter Bloland, Nordin Zeidner, Raphael Kalinga, Robert F Breiman, M Kariuki Njenga.   

Abstract

In January 2007, an outbreak of Rift Valley fever (RVF) was detected among humans in northern Tanzania districts. By the end of the outbreak in June, 2007, 511 suspect RVF cases had been recorded from 10 of the 21 regions of Tanzania, with laboratory confirmation of 186 cases and another 123 probable cases. All confirmed RVF cases were located in the north-central and southern regions of the country, with an eventual fatality rate of 28.2% (N = 144). All suspected cases had fever; 89% had encephalopathy, 10% hemorrhage, and 3% retinopathy. A total of 169 (55%) of the 309 confirmed or probable cases were also positive for malaria as detected by peripheral blood smear. In a cohort of 20 RVF cases with known outcome that were also positive for human immunodeficiency virus, 15 (75%) died. Contact with sick animals and animal products, including blood, meat, and milk, were identified as major risk factors of acquiring RVF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682902      PMCID: PMC2913502          DOI: 10.4269/ajtmh.2010.09-0318

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Rapid particle agglutination test for human immunodeficiency virus: hospital-based evaluation.

Authors:  Sandeep Ramalingam; Rajesh Kannangai; Antony Raj A; Mary V Jesudason; Gopalan Sridharan
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis.

Authors:  Kum Thong Wong; Wun-Ju Shieh; Shalini Kumar; Karim Norain; Wahidah Abdullah; Jeannette Guarner; Cynthia S Goldsmith; Kaw Bing Chua; Sai Kit Lam; Chong Tin Tan; Khean Jin Goh; Heng Thay Chong; Rani Jusoh; Pierre E Rollin; Thomas G Ksiazek; Sherif R Zaki
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Rift Valley fever outbreak in Egypt. October--December 1977.

Authors:  A M El-Akkad
Journal:  J Egypt Public Health Assoc       Date:  1978

4.  Climate-disease connections: Rift Valley Fever in Kenya.

Authors:  A Anyamba; K J Linthicum; C J Tucker
Journal:  Cad Saude Publica       Date:  2001       Impact factor: 1.632

Review 5.  Rift Valley fever: an uninvited zoonosis in the Arabian peninsula.

Authors:  Hanan H Balkhy; Ziad A Memish
Journal:  Int J Antimicrob Agents       Date:  2003-02       Impact factor: 5.283

6.  Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans.

Authors:  Mohammed Al-Hazmi; Ephraim Ayobanji Ayoola; Mahmoud Abdurahman; Subodh Banzal; Jammal Ashraf; Adil El-Bushra; Ali Hazmi; Mohammed Abdullah; Hamid Abbo; Abdulhadi Elamin; El-Tayeb Al-Sammani; Mohammed Gadour; Chandra Menon; Mirghani Hamza; Inam Rahim; Magdy Hafez; Manish Jambavalikar; Haider Arishi; Ali Aqeel
Journal:  Clin Infect Dis       Date:  2003-01-17       Impact factor: 9.079

7.  A retrospective study of Rift Valley fever in Saudi Arabia.

Authors:  A I Al-Afaleq; E M E Abu Elzein; S M Mousa; A M Abbas
Journal:  Rev Sci Tech       Date:  2003-12       Impact factor: 1.181

8.  Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

Authors:  Christian Drosten; Stephan Göttig; Stefan Schilling; Marcel Asper; Marcus Panning; Herbert Schmitz; Stephan Günther
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

9.  Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2.

Authors:  G E L van den Berk; P H J Frissen; R M Regez; P J G M Rietra
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01.

Authors:  Trevor Shoemaker; Carla Boulianne; Martin J Vincent; Linda Pezzanite; Mohammed M Al-Qahtani; Yagub Al-Mazrou; Ali S Khan; Pierre E Rollin; Robert Swanepoel; Thomas G Ksiazek; Stuart T Nichol
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  89 in total

1.  Rift Valley Fever: scientific pathways toward public health prevention and response.

Authors:  Robert F Breiman; Bruno Minjauw; S K Sharif; Peter Ithondeka; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.

Authors:  Aaron W Walters; Michael R Kujawa; Joseph R Albe; Douglas S Reed; William B Klimstra; Amy L Hartman
Journal:  Virology       Date:  2018-11-02       Impact factor: 3.616

3.  Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus.

Authors:  Leonard Nderitu; John S Lee; Jared Omolo; Sylvia Omulo; Monica L O'Guinn; Allen Hightower; Fausta Mosha; Mohamed Mohamed; Peninah Munyua; Zipporah Nganga; Kelli Hiett; Bruce Seal; Daniel R Feikin; Robert F Breiman; M Kariuki Njenga
Journal:  J Infect Dis       Date:  2010-12-14       Impact factor: 5.226

4.  Rift Valley Fever Seroprevalence in Coastal Kenya.

Authors:  Elysse N Grossi-Soyster; Tamara Banda; Crystal Y Teng; Eric M Muchiri; Peter L Mungai; Francis M Mutuku; Ginny Gildengorin; Uriel Kitron; Charles H King; A Desiree Labeaud
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

5.  Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance.

Authors:  Serena A Carroll; Jean-Marc Reynes; Marina L Khristova; Soa Fy Andriamandimby; Pierre E Rollin; Stuart T Nichol
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

6.  Climate Influence on Emerging Risk Areas for Rift Valley Fever Epidemics in Tanzania.

Authors:  Clement N Mweya; Leonard E G Mboera; Sharadhuli I Kimera
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

7.  Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.

Authors:  Todd M Bell; Virginia Espina; Svetlana Senina; Caitlin Woodson; Ashwini Brahms; Brian Carey; Shih-Chao Lin; Lindsay Lundberg; Chelsea Pinkham; Alan Baer; Claudius Mueller; Elizabeth A Chlipala; Faye Sharman; Cynthia de la Fuente; Lance Liotta; Kylene Kehn-Hall
Journal:  Antiviral Res       Date:  2017-04-23       Impact factor: 5.970

8.  Ultrastructural pathology of human liver in Rift Valley fever.

Authors:  Mubarak Al Shraim; Refaat Eid; Khaled Radad; Noora Saeed
Journal:  BMJ Case Rep       Date:  2016-08-02

9.  Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania.

Authors:  Augustino Alfred Chengula; Christopher Jacob Kasanga; Robinson Hammerthon Mdegela; Raphael Sallu; Mmeta Yongolo
Journal:  Trop Anim Health Prod       Date:  2014-01-24       Impact factor: 1.559

10.  Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.

Authors:  Elizabeth R Wonderlich; Amy L Caroline; Cynthia M McMillen; Aaron W Walters; Douglas S Reed; Simon M Barratt-Boyes; Amy L Hartman
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.